
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Specialised endoscopes called duodenoscopes are employed mostly during ERCP. These endoscopes have the benefit of allowing you to see the major duodenal papilla en-face since they see the patient from the side rather than the front. With a duodenoscope, the elevator at the endoscope's tip is operated by a lever.
The endoscopist can raise and lower tools inserted into the working channel so they are in the field of view by adjusting the elevator. They therefore make it easier to gain access to the pancreatic and bile ducts, which is beneficial for cannulating the papilla.
The Global Duodenoscope market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The new TJF-Q190V duodenoscope from Olympus has been made accessible in the market.
In order to treat patients who require ERCP (endoscopic retrograde cholangiopancreatography), a difficult procedure, doctors can now use a duodenoscope of the most recent generation that contains improvements that offer better imaging and even more therapeutic manoeuvrability.
an enhanced cannulation efficiency is made possible by a vertical field of vision that is 20% larger than that of the previous generation of duodenoscopes.
High Force Transmission technology is used, providing responsive manoeuvrability and clear tactile feedback for precise control throughout the procedure.
A disposable distal cover and a manual flushing adapter are two additional safety features on the TJF-Q190V duodenoscope that are intended to increase the effectiveness of reprocessing.
These safety improvements were made in response to the FDA's request for duodenoscopes with disposable components that make it easier to reach the elevator mechanism for reprocessing.
Olympus endoscopes have a well-deserved reputation as the "gold standard" due to its ongoing innovation in handling and visualisation.
The TJF-Q190V pushes that standard even further; this duodenoscope of the most recent generation incorporates both significant clinical breakthroughs and design elements for more effective reprocessing.
The full market launch of this device, which demonstrates their dedication to patient safety while simultaneously enhancing physicians' abilities, makes them ecstatic.
To speed up the market transition to this new duodenoscope, Olympus is providing unheard-of trade-in values for older generation duodenoscopes.
Additionally, Olympus is including a Premium Protection Plan with every purchase. This plan pays for service checks after 100 uses or once a year, whichever comes first.
The DEC HD Duodenoscope, an innovative, high-definition duodenoscope with multiple disposable components, including the sterile distal cap and elevator lever, for unit reprocessing, has been introduced in the United States, according to PENTAX Medical, a leader in the healthcare industry for diagnostic and therapeutic endoscopy.
The DEC HD Duodenoscope is intended to give physicians a solution that is in line with recent FDA advice on lowering endoscope reprocessing and to produce concrete 'Triple Aim'1 value (by boosting clinical results, lowering healthcare costs, and improving physician and patient experiences).
The device has just acquired FDA authorization, enabling its commercial introduction in the US, and has been available on marketplaces across the world.
Despite adequate reprocessing following ERCP operations, conventional duodenoscopes are associated with an increased risk of infection.
The FDA recently released a safety communication in which it stated: "To lower the risk of patient infection, FDA advises health care providers and manufacturers to begin switching to duodenoscopes with disposable components.
The best way to lower the danger of disease transmission via duodenoscopes is to create cutting-edge devices with disposable components or other design features that make reprocessing quicker, more efficient, or unnecessary.
Another significant step towards reducing the risk of infection among patients who have procedures with these devices is the development of duodenoscopes with a disposable elevator component.
The DEC is an advanced, hygienic endoscopic solution that maintains the imaging and handling performance doctors need during endoscopic retrograde cholangiopancreatography (ERCP) procedures.
It was developed by PENTAX Medical in response to the FDA's and CDC's calls for advancement in duodenoscope design to increase patient safety. Since the lift is the part most susceptible to intestinal pathogens, the DEC enables doctors to dispose of it quickly and safely.
The DEC HD Duodenoscope has a sterile, disposable distal cap AND a disposable elevator, which helps to lower the possibility of bioburden still being present on traditional elevator components after reprocessing.
Due to fewer steps in the reprocessing process, the workload associated with time-consuming reprocessing (also known as cleaning) is lessened.
The sterile and disposable distal end cap with integrated elevator, along with the competency-based training and reprocessing methods that have been verified by human factors, make up the DEC, which represents a substantial clinical advance in both device design and patient safety.
The DEC was especially created in response to the evidence-based recommendations made public by the FDA and CDC, and it represents a significant advancement in terms of raising patient safety, lowering contamination, and enhancing endoscope reprocessing initiatives.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |